SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — Kyntra Bio, Inc. (KYNB) on Monday reported third-quarter profit of $157,000.
The San Francisco-based company said it had profit of 4 cents per share. Losses, adjusted for non-recurring gains, were $3.42 per share.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $3.66 per share.
The biotech drug developer posted revenue of $1.8 million in the period, which missed Street forecasts. Three analysts surveyed by Zacks expected $2 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KYNB at https://www.zacks.com/ap/KYNB